METHADONE Drug Patent Profile
✉ Email this page to a colleague
When do Methadone patents expire, and what generic alternatives are available?
Methadone is a drug marketed by Hikma, Lannett Co Inc, Specgx Llc, Vistapharm Llc, Breckenridge, Long Grove Pharms, Mylan Institutional, Mallinckrodt Inc, Ascent Pharms Inc, Aurolife Pharma Llc, Elite Labs Inc, Epic Pharma Llc, Roxane, Sun Pharm Industries, and Thepharmanetwork Llc. and is included in twenty-nine NDAs.
The generic ingredient in METHADONE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methadone
A generic version of METHADONE was approved as methadone hydrochloride by HIKMA on March 8th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHADONE?
- What are the global sales for METHADONE?
- What is Average Wholesale Price for METHADONE?
Summary for METHADONE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 29 |
| Drug Prices: | Drug price information for METHADONE |
| DailyMed Link: | METHADONE at DailyMed |


